FMR1-related measures, including CGG repeat number, percent of methylation, FMR1 mRNA and FMRP expression levels have been correlated to neurocognitive and social–affective functioning assessments and mental health problems in individuals with FXS [30,31,32,33,34,35,36,37,38]. The gene discussed is FMR1; the disease is fragile X syndrome.